(PM) Philip Morris International - NYSE
Sector: Consumer Defensive | Industry: Tobacco | Exchange: NYSE (USA) | Market Cap: 287.242m USD | Total Return: 2.7% in 12m
Avg Turnover: 766M
EPS Trend: 97.2%
Qual. Beats: 1
Rev. Trend: 99.6%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Philip Morris International Inc. (PM) is a global tobacco and nicotine company headquartered in Stamford, Connecticut. Its portfolio includes traditional cigarettes and a growing range of smoke-free alternatives, such as heat-not-burn devices, e-vapor products, and oral nicotine pouches under brands like IQOS and ZYN.
The company operates within the consumer staples sector, a category often characterized by inelastic demand and high barriers to entry due to stringent global regulations. Philip Morris is currently executing a business model transition, shifting capital allocation away from combustible tobacco toward reduced-risk products to address evolving consumer preferences and public health policies.
Investors can further examine these shifting product mix trends on ValueRay. This strategic pivot involves significant investment in proprietary technology and wellness products, moving the company beyond its historical reliance on traditional cigarette manufacturing.
- ZYN nicotine pouch volume growth accelerates in the United States market
- Rapid IQOS expansion offsets structural declines in combustible cigarette shipment volumes
- Global currency fluctuations significantly impact reported net revenue and operating cash flows
- Increasing tobacco excise taxes and strict marketing regulations pressure operating margins
- High dividend yield and debt refinancing costs influence investor valuation premiums
| Net Income: 11.1b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA -0.19 > 1.0 |
| NWC/Revenue: -1.49% < 20% (prev -15.35%; Δ 13.85% < -1%) |
| CFO/TA 0.18 > 3% & CFO 12.2b > Net Income 11.1b |
| Net Debt (46.5b) to EBITDA (17.3b): 2.69 < 3 |
| Current Ratio: 0.98 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.56b) vs 12m ago 0.44% < -2% |
| Gross Margin: 67.30% > 18% (prev 65.68%; Δ 1.62% > 0.5%) |
| Asset Turnover: 61.93% > 50% (prev 58.98%; Δ 2.95% > 0%) |
| Interest Coverage Ratio: 9.65 > 6 (EBIT TTM 15.3b / Interest Expense TTM 1.58b) |
| A: -0.01 (Total Current Assets 25.6b - Total Current Liabilities 26.2b) / Total Assets 68.9b |
| B: 0.52 (Retained Earnings 35.5b / Total Assets 68.9b) |
| C: 0.23 (EBIT TTM 15.3b / Avg Total Assets 67.0b) |
| D: -0.12 (Book Value of Equity -9.28b / Total Liabilities 76.2b) |
| Altman-Z'' = 3.03 = A |
| DSRI: 1.02 (Receivables 6.39b/5.79b, Revenue 41.5b/38.4b) |
| GMI: 0.98 (GM 65.68% / 67.30%) |
| AQI: 0.94 (AQ_t 0.51 / AQ_t-1 0.54) |
| SGI: 1.08 (Revenue 41.5b / 38.4b) |
| TATA: -0.02 (NI 11.1b - CFO 12.2b) / TA 68.9b) |
| Beneish M = -3.01 (Cap -4..+1) = AA |
As of June 17, 2026, the stock is trading at USD 184.06 with a total of 3,486,157 shares traded.
Over the past week, the price has changed by +3.27%,
over one month by -4.11%,
over three months by +4.95% and
over the past year by +2.71%.
Philip Morris International has received a consensus analysts rating of 4.06. Therefore, it is recommended to buy PM.
- StrongBuy: 7
- Buy: 5
- Hold: 4
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 193.9 | 5.3% |
P/E Trailing = 25.9577
P/E Forward = 21.4592
P/S = 6.7901
P/B = 1318.6993
P/EG = 2.5228
Revenue TTM = 41.5b USD
EBIT TTM = 15.3b USD
EBITDA TTM = 17.3b USD
Long Term Debt = 43.8b USD (from longTermDebt, last quarter)
Short Term Debt = 8.14b USD (from shortTermDebt, last quarter)
Debt = 51.9b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 46.5b USD (calculated: Debt 51.9b - CCE 5.45b)
Enterprise Value = 334b USD (287b + Debt 51.9b - CCE 5.45b)
Interest Coverage Ratio = 9.65 (Ebit TTM 15.3b / Interest Expense TTM 1.58b)
EV/FCF = 31.29x (Enterprise Value 334b / FCF TTM 10.7b)
FCF Yield = 3.20% (FCF TTM 10.7b / Enterprise Value 334b)
FCF Margin = 25.71% (FCF TTM 10.7b / Revenue TTM 41.5b)
Net Margin = 26.74% (Net Income TTM 11.1b / Revenue TTM 41.5b)
Gross Margin = 67.30% ((Revenue TTM 41.5b - Cost of Revenue TTM 13.6b) / Revenue TTM)
Gross Margin QoQ = 68.06% (prev 65.64%)
Tobins Q-Ratio = 4.84 (Enterprise Value 334b / Total Assets 68.9b)
Interest Expense / Debt = 3.05% (Interest Expense 1.58b / Debt 51.9b)
Taxrate = 19.20% (2.75b / 14.3b)
NOPAT = 12.3b (EBIT 15.3b * (1 - 19.20%))
Current Ratio = 0.98 (Total Current Assets 25.6b / Total Current Liabilities 26.2b)
Debt / Equity = -5.60 (negative equity) (Debt 51.9b / totalStockholderEquity, last quarter -9.28b)
Debt / EBITDA = 2.69 (Net Debt 46.5b / EBITDA 17.3b)
Debt / FCF = 4.36 (Net Debt 46.5b / FCF TTM 10.7b)
Total Stockholder Equity = -10.5b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.56% (Net Income 11.1b / Total Assets 68.9b)
RoE = -105.3% (negative equity) (Net Income TTM 11.1b / Total Stockholder Equity -10.5b)
RoCE = 45.93% (EBIT 15.3b / Capital Employed (Equity -10.5b + L.T.Debt 43.8b))
RoIC = 25.33% (NOPAT 12.3b / Invested Capital 48.8b)
WACC = 4.73% (E(287b)/V(339b) * Re(5.14%) + D(51.9b)/V(339b) * Rd(3.05%) * (1-Tc(0.19)))
Discount Rate = 5.14% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 93.09 | Cagr: 0.17%
[DCF] Terminal Value 76.03% ; FCFF base≈10.5b ; Y1≈10.9b ; Y5≈12.5b
[DCF] Fair Price = 93.71 (EV 193b - Net Debt 46.5b = Equity 146b / Shares 1.56b; r=8.35% [WACC [floored]]; 5y FCF grow 4.62% → 2.50% )
EPS Correlation: 97.19 | EPS CAGR: 11.14% | SUE: 3.02 | # QB: 1
Revenue Correlation: 99.63 | Revenue CAGR: 7.97% | SUE: 1.40 | # QB: 1
EPS current Quarter (2026-06-30): EPS=2.06 | Chg30d=+0.91% | Revisions=-25% | Analysts=10
EPS next Quarter (2026-09-30): EPS=2.43 | Chg30d=+0.19% | Revisions=-14% | Analysts=10
EPS current Year (2026-12-31): EPS=8.42 | Chg30d=+0.09% | Revisions=-20% | GrowthEPS=+11.7% | GrowthRev=+6.9%
EPS next Year (2027-12-31): EPS=9.13 | Chg30d=-0.20% | Revisions=-11% | GrowthEPS=+8.4% | GrowthRev=+6.3%
[Analyst] Revisions Ratio: -25%